X0609 4 2026-08-20 0 0001054102 INTERPACE BIOSCIENCES, INC. IDXG 0001720219 Burnell Thomas W. false C/O INTERPACE BIOSCIENCES, INC. 2001 ROUTE 46 WATERVIEW PLAZA, SUITE 310 PARSIPPANY NJ 07054 1 1 0 0 CEO, President & Chairman 0 Common Stock 2026-08-20 4 M 0 1966763 0 A 2037645 D Common Stock 2026-08-20 4 F 0 581718 1.61 D 1455927 D Common Stock 10885 I By spouse Restricted Stock Units 2026-08-20 4 A 0 1966763 0 A Common Stock 1966763 1966763 D Restricted Stock Units 2026-08-20 4 M 0 1966763 0 D Common Stock 1966763 0 D Stock Option (right to buy) 2.02 2026-08-20 4 A 0 554018 0 A 2036-08-20 Common Stock 554018 554018 D Represents the conversion upon vesting of restricted stock units ("RSUs") into shares of common stock of Interpace Biosciences, Inc. (the "Issuer"). On August20, 2026, the Reporting Person was granted 1,966,763 RSUs, all of which vested upon grant and which amount includes an amount intended to satisfy the Reporting Person's tax obligations arising from the award. Represents shares returned to the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person received the net number of shares after the shares were returned to the Issuer to satisfy applicable tax withholding obligations. Each RSU represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc. On August 20, 2026, the Reporting Person was granted 1,966,763 RSUs, all of which vested upon grant and which amount includes an amount intended to satisfy the Reporting Person's tax obligations arising from the award. The options will vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date. /s/ Thomas W. Burnell 2026-08-20